DexCom, Inc.
DXCM
$79.32-0.87 (1.08%)Nov 20
After-hours: $79.32 (+0.00%)
DexCom, Inc. (DXCM)
$79.32-0.87-1.08%Nov 20
Loading chart…
YTD20%
M.cap.29.6 bn
Std.Dev, 1y0.60
Vol, bn0.4 (med)
RSI40
P/E30.2
MFI37
P/S5.73
ADX17 (no trend)
P/B11.67
Beta1.37
Div—
Debt/EBITDA1.02
Payout—
Price target
Buy 20 (95%)Hold 1 (5%)Sell 0 (0%)
Next earnings11 Feb, after close
Earnings surprise
Short interest4.2% (+0.1%), 30 Oct 2026
Fund owners #897 (-124)
Insider ownership$159 mm
Insider sellingMedium
Insider buying—
General
M.Cap$29.6B
Dividends—
Next report11 Feb, after close
Forecast
Valuation
Target
P/E30.2
P/S5.73
P/B11.67
Fundamentals
5-y avg sales growth+19.3%
Debt / EBITDA1.02
ROE30.5%
Altman Z-score6.43 (safe)
Technicals
RSI40
MFI37
Price / MA50-5.5% (low) ↓
Trend pattern
Financial Statements
No data available
Financial Statements
No data available
Team
Loading…
Team
Loading…
Leadership Changes
Sign in to view leadership changes
Sign in
No changes found
Insider Activity
Loading…
Insider Activity
Loading…
DateTypeDescription
Loading…
Earnings Transcripts
Loading…
Earnings Transcripts
Loading…
Dividends
Loading…
Dividends
Loading…
Investor Presentations
Loading…
Investor Presentations
Loading…
Options
Exp. from:to:
Strike from:to:
Loading…
Options
Expiration from:
to:
Strike from:
to:
Loading options…
Loading bonds…
Stress Test
Loading…
Stress Test
Loading…
About

DexCom, Inc. is a medical device company that creates and sells continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. Their products include DexCom G6, Real-Time API, ONE, and Share, with their upcoming product being DexCom G7, a newer CGM system. They collaborate and have a partnership with Verily Life Sciences LLC and Verily Ireland Limited.

WikipediaHeadcount: 11,000
Address:6340 Sequence Drive, San Diego, CA, United States, 92121
About

DexCom, Inc. is a medical device company that creates and sells continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. Their products include DexCom G6, Real-Time API, ONE, and Share, with their upcoming product being DexCom G7, a newer CGM system. They collaborate and have a partnership with Verily Life Sciences LLC and Verily Ireland Limited.

https://www.dexcom.com
Beta 1.37